top of page
.jpg)
Our Publications
As trailblazers in Molecular Endocrinology, CoRegen's scientists are renowned experts in the biology of the SRC gene family, with over 300 publications in prestigious, peer-reviewed journals.
-
40+ years of pharma and biotech leadership
-
Six companies reached values or sold for $1B+
-
Notably, Medivation was acquired by Pfizer for $14.2B
-
30+ Years of Experience
-
Professor of Molecular and Cell Biology & Molecular
Regulation at Baylor College of Medicine -
Developed Strategies for Regulating Molecular Processes
-
45+ years of experience in public and private sector finance
-
Served as CFO for CytRx, Medicis, EntreMed, ClearPoint, DARA and BioSciences Companies
bottom of page